Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/15/2025

Diagnosis and Management of Supraventricular Tachycardia (SVT)

Clinical Presentation and Diagnosis

  • Narrow complex tachycardia at 250-300 bpm is characteristic of SVT in infants, distinguishing it from ventricular tachycardia which typically presents with wide QRS complexes, according to the European Heart Journal 1
  • The heart rate range of 250-300 bpm is characteristic for SVT in infants, whereas atrial flutter typically presents with atrial rates of 300-400 bpm with variable AV block, as noted in the European Heart Journal 1
  • Atrial flutter in infants typically shows characteristic "sawtooth" flutter waves and atrial rates of 300-400 bpm with 2:1 or variable AV block, resulting in ventricular rates of 150-200 bpm, not the 250-300 bpm described, according to the European Heart Journal 1
  • Ventricular tachycardia would present with wide complex tachycardia, not narrow complex as described in this case, as stated in the European Heart Journal 1 and the Journal of the American College of Cardiology 4
  • Syncope in this context represents hemodynamic compromise from the sustained rapid heart rate, which is life-threatening, according to the Journal of the American College of Cardiology 2 and 3

Management and Treatment

  • The American Heart Association guidelines emphasize that in patients with malignant episodes of syncope, ruling out life-threatening arrhythmias like SVT takes priority, as stated in the Journal of the American College of Cardiology 4 and 2
  • The American College of Cardiology emphasizes that underlying heart disease makes syncope potentially life-threatening in pediatric patients, and never assume this is a benign neurocardiogenic syncope in a pediatric patient with documented tachycardia and heart failure, according to the Journal of the American College of Cardiology 2 and 3
  • Echocardiogram to assess for structural heart disease and evaluate ventricular function given the heart failure presentation is recommended, as noted in the European Heart Journal 1 and the Journal of the American College of Cardiology 5

REFERENCES